Skip to main content

Roche’s Virtual Immunology/SLEuro Investor Event

Roche has hosted a virtual event on Monday, 9 March 2026

Agenda
Agenda
IntroductionBruno Eschli, Head of Investor Relations
Immune-mediated kidney & rheumatological diseases pipeline updateJay Garg, VP Global Franchise Head of Nephrology
Ph III (ALLEGORY) Gazyva in SLERichard A. Furie, MD, Chief, Division of Rheumatology, Northwell Health, Marilyn and Barry Rubenstein Chair in Rheumatology and Professor of Medicine, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Q&A

Webinar Replay

Please click the video below to watch the replay of the webinar.

InvestorsPast IR Events
View more Events

Discover more

  • Governance

    About Roche

    Our corporate governance principles focus on sustainable value creation and promote a culture that recognises standards of good corporate governance and a commitment to transparent communication.

  • Product Development Pipeline

    Solutions

    Discover our pipeline of Pharmaceutical and Diagnostics developments

  • Frequently asked questions

    Investors

    We answer the Roche investors-related most frequently asked questions

  • Finance Information Tool

    Investors

    Access the finance information tool for the latest Roche financial data.